baber/WOPTO huggingface dataset:
Patent JP-2000508287-A (JP)
Title: 放射線硬化内側第一被覆と光学ガラス繊維との間の接着性を増大する方法
IPC: C03C25/12
Filed: 1997-04-09
Abstract: (57)【要約】
本発明は、放射線硬化した内側第一光学ガラス繊維被覆の光学ガラス繊維に対する接着性を増大する方法において、１）放射線硬化性光学ガラス繊維被覆組成物との結合を誘起するのに充分なレベルの放射電子ビームに前記光学ガラス繊維の少なくとも一部分を露出し、２）前記電子ビームに露出した光学ガラス繊維に放射線硬化性光学ガラス繊維被覆組成物を適用し、然も、前記被覆組成物は、化学放射線の存在下で遊離ラジカルを形成することができる放射線硬化性官能基を有する少なくとも一種類の単量体又はオリゴマーを含み、そして３）前記被覆した光学ガラス繊維を化学放射線に露出し、それにより前記内側第一被覆を硬化する、諸工程からなる方法に関する。
Patent JP-H11505727-A (JP)
Title: 減カロリー冷凍デザート
IPC: A23G9/34
Filed: 1996-05-31
Abstract: (57)【要約】
スクロース（ｓｕｃｒｏｓｅ）とコーンシロップ固形分なしに製造され、バルク甘味料としてラクチトールと水素化デンプン加水分解物を使用する改善された冷凍デザートが提供される。アスパルテイム、アセスルフエイムＫ又は他の人工甘味料を強力甘味料として使用してもよい。その調製品は少なくとも、スクロースとコーンシロップ固形分で甘味付けした従来の製品と同程度に好ましくそして更にスクロースとコーンシロップ固形分で甘味付けした従来の製品と好ましく比較できる硬度、融解度とオーバーラン特性を示す。
Patent JP-2000513711-A (JP)
Title: 癌の治療法
IPC: A61K38/05
Filed: 1997-04-15
Abstract: (57)【要約】
本発明は、哺乳動物患者に、有効量の、ゲラニルゲラニル−タンパク質転移酵素Ｉ型阻害剤とファルネシル−タンパク質転移酵素阻害剤の組合せを投与することを特徴とする癌の治療方法に関する。本発明は更に、哺乳動物患者に、有効量の、ゲラニルゲニル−タンパク質転移酵素Ｉ型の選択的阻害剤とファルネシル−タンパク質転移酵素の選択的阻害剤の組合せを投与することを特徴とする癌の治療方法に関する。
Patent JP-H11514813-A (JP)
Title: スポット位置表示信号発生
IPC: H04N1/047
Filed: 1997-04-14
Abstract: (57)【要約】
スポット位置表示信号（Ａ）を、アドレス発生器（４）によって発生させる。ラスタ走査陰極線管（２）の１方向の電子ビームスポットを偏向させる偏向電流（Ｉｈ，Ｉｖ）は、近似的な線形走査を１方向に行う形状を有する。アドレス発生器（４）は、スポット位置に関連するスポット位置表示信号（Ａ）を発生させる。スポット位置表示信号が線形的な時間関数である場合、Ａ（ｔ）＝Ａ０＋ｄＡ．ｔとなり、二つの予め決定された（所望の）アドレス（Ａ１，Ａ２）が、画像管スクリーン上の二つの位置に属する偏向電流の二つの予め選択されたレベル（Ｉ１，Ｉ２）で発生する。
Patent JP-2002516647-A (JP)
Title: 環境走査型電子顕微鏡用の気体後方散乱電子検出器
IPC: H01J37/244
Filed: 1999-01-18
Abstract: (57)【要約】
ＥＳＥＭ試料チャンバーの気体環境内に位置する検出器組立体により、試料から放出される後方散乱電子信号のみを検出可能である環境走査型電子顕微鏡を提供する。この検出器組立体は、バイアスがかけられた変換器プレート及びコレクショングリッド/コレクションプレート/コレクターリング配置を含む。一次ビームは変換器プレートに形成された最終圧制限穴を通過し、それからサンプルに衝突する前にコレクショングリッド/プレート/リングの中央穴を通過する。コレクショングリッドは接地電位に保持され、したがってサンプルで発生した二次電子信号を集めない。後方散乱電子はコレクターグリッド/プレート/リングにより集められず、変換後方散乱電子を発生させる変換器プレートに衝突する。変換後方散乱電子は変換器プレートとコレクショングリッドの間に生じた電界により、気体中で増幅される。結果として、コレクショングリッド/プレート/リングはサンプルからの二次電子信号は集められないが、増幅された変換後方散乱電子信号のみを集める。さらにこの専用気体後方散乱電子検出器は、二次電子検出、後方散乱電子検出又は双方の相互間で容易に切替え可能である簡単で、低コスト電子検出器を製造するために利用される。
Patent JP-2000509810-A (JP)
Title: 種子の成熟度及び品質を決定するための方法並びに種子の種分けのための装置
IPC: G01N21/64
Filed: 1997-04-28
Abstract: (57)【要約】
本発明はクロロフィル蛍光量を測定することによる種子の成熟度及び品質の評価のための種子種分けのための方法及び装置に関する。この方法は種子エンベロープ及びその種子エンベロープにおいて亀裂が存在する場合に目に見えるようになるクロロフィル含有組織のクロロフィル蛍光の量の測定に基づく。本発明は種子に適当な波長の電磁線を照射することによりクロロフィル分子の蛍光を誘導し、そしてクロロフィル蛍光を測定することより成る。この方法の特徴は非常に高感度であり、非破壊的であり、且つ非常に高速度である点にある。本発明のこれらの特徴は種子をクロロフィルの量に基づき選別できうる種分け装置の構築を可能にする。クロロフィル蛍光の強度は成熟度及び種子エンベロープにおける亀裂の存在に直接関連するため、種子をその品質に基づき種分けすることが可能である。白色キャベツ、テンサイ、ニンジン、コショウ及びトマト由来の種子の実験を記述する。
Patent JP-2001519975-A (JP)
Title: モノリシック・マイクロ波集積回路のための高性能ミクサ構造
IPC: H01P3/08
Filed: 1997-02-21
Abstract: (57)【要約】
２つのバラン（５６，６４）、四分の一波長伝送線（７４）及びダイオード・カッド（７２）が、ＭＭＩＣミクサを形成するようチップ上で結合され、そして一対のミクサが、９０度及び１８０度スプリッタと結合されて、特定のスプリアス信号の優れた拒絶並びに少ないＲＦ及びＬＯの漏れをもった回路を提供する。２つのバラン（５６，６４）は、２つの金属層を有するチップ基板上に形成されるミニマイクロストリップ及びミニ共面伝送線を備える。基板の下側の接地面と一緒に、線は、マーチャンド・バラン（５６，６４）を形成するように接続される。
Patent JP-2002511165-A (JP)
Title: 特徴制約に基づく文書情報の取得と配信
IPC: G06F17/30
Filed: 1998-04-23
Abstract: (57)【要約】
システムが、複数のワークステーション、ファイルサーバ、プリンタ、およびその他のネットワークを介して接続された据置型装置、および赤外（ＩＲ）リンクによってネットワークに接続される、ユーザ携行型の複数の携帯型装置を含む。各携帯型装置は、該装置のユーザの文書用個人サチェルをエミュレートする、つまり当該装置は、特徴制約（ＦＣ）の送受信及び格納をするようプログラムされている。ＦＣは、ＩＲデータパケット送信によって利用者間で配信され、ネットワークに接続されたコンピュータ、プリンタ、または多機能装置が、付属のＩＲ無線機を介してＦＣを受信すると、サーチリクエストがこのＦＣから抽出され、このＦＣを充足する文書指示子（例えばＷＷＷのＵＲＬ）がサーチエンジンを介して得られる。得られた各ＵＲＬについて、対応する電子文書が記憶領域から取得された後、表示あるいは印刷される。携帯型装置として、ユーザによるＦＣ転送が可能なグラフィック表示部を有した、ハンドヘルドあるいは腕時計型コンピュータが好ましい。好適な据置型装置は、ＩＲ無線機を内蔵した、スキャナ、複写機、またはプリンタを含むものである。
Patent JP-2002515811-A (JP)
Title: 剥離を決定する方法および装置
IPC: A61B5/042
Filed: 1998-05-01
Abstract: (57)【要約】
部位を剥離するための電気生理学的処置に使用のカテーテル（１４）は、第１の仕事関数を有しかつＲＦエネルギ源により付勢される金属先端部（３０）を含む。ＲＦエネルギの戻り経路は、第２の仕事関数を有しかつ剥離部位から外れた第２の場所に配設されている金属材料の比較的大きなプレート（３４）を通してである。中間の組織により与えられる電解質が存在する中で動作する先端部とプレートとの間の仕事関数の差は、電荷の交換を化学反応を通して生じ、ガルヴァーニ電池を生成する。ガルヴァーニ電池にシャント抵抗を負荷することにより、ガルヴァーニ電池は、組織損傷の発生を表すピーク値を有する電流信号を供給する電流源となる。この概念作用を用いて、剥離部位に印加されるＲＦエネルギを調整する。
Patent JP-2002512737-A (JP)
Title: マイクロチャンネルプレートを製造するためのシリコンエッチング方法
IPC: H01L21/3063
Filed: 1998-05-08
Abstract: (57)【要約】
マイクロチャンネルプレートのような、細長い孔アスペクト比のチャンネル（３０）を有する素子を、ｐ−タイプシリコン素子（１０）を電解液（２６）において電気化学エッチングに供して素子を透通するチャンネルを形成することによりつくる。電解液は水性電解液とすることができる。マイクロチャンネルプレートとして使用する場合には、チャンネルのシリコン面を絶縁二酸化炭素（２８）に変えることができ、高電子放出性のダイノード材料（３２）をチャンネルの絶縁面に被着することができる。新規のダイノード材料も開示されている。
Patent JP-2002504216-A (JP)
IPC: F24J2/40
Filed: 1998-04-15
Abstract: The facade unit (1) has three plate sections (2, 3, 4). The intermediate space (5) facing the building interior is filled with gas, the exterior intermediate space (6) being filled with a circulating liquid (7) which is dyed or pigmented in such a way that it absorbs infrared light but is at least partially transparent for visible light. This ensures that the building interior is well shaded from heat radiation and provides and efficient means of acquiring heat energy. The efficiency can be increased further by various methods.
Patent JP-2001527572-A (JP)
Title: 実質的に純粋なゾヌリン（ｚｏｎｕｌｉｎ）、哺乳動物密着結合の生理学的な調節因子
IPC: C12N15/09
Filed: 1998-04-28
Abstract: (57)【要約】
哺乳動物密着結合の生理学的な調節因子である、実質的に純粋な哺乳動物タンパク質、本明細書中以後「ゾヌリン」、ならびにこれを使用するための方法が開示される。
Patent NZ-206150-A (NZ)
Title: Food processor; screw conveyor pitch wider in microwave chamber than preheating chamber
Inventor: MACKENZIE R A
IPC: A23L5/10
Filed: 1983-11-04
Abstract: A method and apparatus for processing a foodstuff raw material in particulate form involve preheating the particulate matter in a preheating chamber (6) and then subjecting the preheated matter to heating by microwave energy in a main processing chamber (7). Suitable conveying means (8) are provided to convey the particulate matter through the preheating and main processing sections and the apparatus, including the input (12) thereto and output (9) therefrom, is suitably constructed to prevent dangerous leakage of microwave energy.
Patent NZ-212255-A (NZ)
Title: Oral pharmaceutical composition containing polycyclic medicament which is sparingly soluble in water
Inventor: HARRISON P J
IPC: A61K9/52
Filed: 1985-05-30
Abstract: A pharmaceutical composition comprising a plurality of, beads constituting a unit dose of a solid steroid medicament enclosed in a gastric-juice soluble material, for example gelatin capsules. Each bead comprises finely divided discrete solid steroidal particles bound onto a particulate core by a binder soluble in water.
Patent NZ-215906-A (NZ)
Title: Food browning composition containing hydrolysed collagen or gelatin
Inventor: BRYSON I
IPC: A23L5/40
Filed: 1986-04-21
Abstract: A browning agent particularly for use in microwave cooking comprises collagen, or gelatine hydrolysed to its constituent amido acids, plus one or more reducing sugars and alkalis.The collagen preferably is derived from bovine hides. The alkali is preferably a mixture of sodium carbonate and bicarbonate.The prowning agent is capable of browning at 100°C or less, down to about 70°C.It may be incorporated into a film or used as a powder or a liquid.
Patent NZ-220361-A (NZ)
Title: Distamycin a analogs and pharmaceutical compositions
Inventor: LAZZARI ETTORE
IPC: C07D207/34
Filed: 1987-05-19
Abstract: Distamycin A analogs of the following formula (I): <CHEM>  wherein  n is 2, 3 or 4;  A is a divalent radical chosen from <CHEM> and -Het-, wherein Het is a pentatomic or hexatomic heteromonocyclic ring, except pyrrole, the said radical being unsubstituted or substituted by one or more substituents chosen from C1-C6 alkyl, C1-C6 alkoxy, cyano and trifluoromethyl;  and either one of R1 and R2 is hydrogen and the other is a) a group <CHEM> in which R3 is C1-C6 alkyl unsubstituted or substituted by halogen atoms; phenyl; or cyclohexyl; or b) a group -CO-(CH2)m-R4 in which m is zero, 1, 2 or 3 and R4 is hydrogen, halogen, hydroxy, aziridinyl or oxiranyl; or R1 and R2 are the same and they are both hydrogen or both a C1-C6 alkyl group unsubstituted or substituted by halogen, hydroxy or C1-C6 alkoxy; and the pharmaceutically acceptable salts thereof; are antitumor and antiviral agents.
Patent NZ-225620-A (NZ)
Title: Transporting comestibles in computer controlled atmosphere of reduced oxygen level
Inventor: HARRIS SAMUEL
IPC: A23L3/34
Filed: 1988-07-29
Abstract: A method of transporting a quantity of a comestible which may be subject to degradation as a result of respiration during transportation, comprising the steps of:   (a) sealing or substantially sealing said quantity of the respiring comestible within a container as hereinbefore described sufficiently to ensure that less oxygen of the ambient air can diffuse into the container than is required for full respiration by the respiring comestible, flushing the container with an oxygen low or oxygen free gas so as to provide a reduced oxygen level in the sealed or substantially sealed container, such flushing occurring before, during and/or after said sealing or substantial sealing, and (b) transporting the container with the respiring comestible therein while (i) monitoring the oxygen level within said container and automatically adjusting the oxygen level as necessary by a positive infusion of ambient air into the container in response to such monitoring towards an optimum or predetermined value or range of values and (ii) monitoring the carbon dioxide level within said container and adjusting the carbon dioxide level as necessary in response to such monitoring towards an optimum or predetermined value or range of values without reliance upon flushing with an oxygen low or oxygen free gas, said adjustment being firstly by means of a scrubbing of the air within said container but if necessary may additionally or instead include a positive infusion of ambient air into the container. h
Patent NZ-225869-A (NZ)
Title: Radiation-sensitive compound and production of lithographic printing plates
Inventor: WHITE NICHOLAS JOHN
IPC: G03F7/00
Filed: 1988-08-18
Abstract: A radiation sensitive compound is a trimer of <CHEM>  or has the formula <CHEM> wherein R<1> and R<2>, are alkyl, aryl, X, CHX2, CH2X, CX3 or NHR<3> wherein R<3> represents hydrogen, lower alkyl, aryl or @ A<2>,    R<4> represents NCO or R<2> provided that R<3> is not @ - A<2>,   and provided at least one of R<1>, and R<2> and R<4> is CX3, X is halogen, and A<1> and A<2> are each residues of A<1>-H and A<2>-H respectively wherein A<1>-H and A<2>-H are each compounds containing at least one group having an active hydrogen atom. The compounds are useful as initiators and colour change indicators in radiation sensitive compositions for lithographic printing plate production.
Patent NZ-227415-A (NZ)
Title: (+)-4,9 dihydro-3-methyl-4-((4-methyl-1-piperazinyl) acetyl)-10h-thieno(3,4-b)(1,5)benzodiazepin-10-one and pharmaceutical compositions
Inventor: ULRICH WOLF-RUDIGER
IPC: C07D495/04
Filed: 1988-12-20
Abstract: PCT No. PCT/EP88/01173 Sec. 371 Date Jun. 15, 1990 Sec. 102(e) Date Jun. 15, 1990 PCT Filed Dec. 19, 1988 PCT Pub. No. WO89/05644 PCT Pub. Date Jun. 29, 1989.The invention relates to the use of telenzepine and (+)-telenzepine in the treatment of bronchial diseases. Furthermore, the the invention relates to (+)-telenzepine, a process for its preparation and intermediates for its preparation.
Patent NZ-228566-A (NZ)
Title: 1-dimethylcarbamoyl-3,5-disubstituted-1h-1,2,4-triazoles and insecticidal compositions
Inventor: JACOBSON RICHARD MARTIN
IPC: C07D249/12
Filed: 1989-03-31
Abstract: 1-Dimethylcarbamoyl-1H-1,2,4-triazoles of general formula I <CHEM>  wherein W      is t-butyl, s-butyl, i-propyl, cyclopropyl, 1-methylthio-1-methylethyl or 1-methyl-cycloprop-1-yl;  X      is <CHEM> R<1>      is substituted or unsubstituted -(CH2)n-, or substituted or unsubstituted phenylene R<2>      and R<3> are selected from a number of different substituents, and n      is 1 to 10, and agronomically acceptable salts thereof, are insecticidally active and can be used to combat insects, especially aphids.
Patent NZ-247648-A (NZ)
Title: Self-sticking matrix system for the sustained release of piribedil
Inventor: CUINE ALAIN
IPC: C07D405/12
Filed: 1993-05-19
Abstract: Matrix system made up of ethylene/vinyl acetate copolymer, self-adhesive for the extended release of piribedil. This system ensures the continuous and uniform diffusion of piribedil by a transcutaneous route.
Patent NZ-272489-A (NZ)
Title: Pyrazolyl derivatives and pesticidal compositions
Inventor: KIRSTGEN REINHARD
IPC: C07D231/16
Filed: 1995-07-03
Abstract: 2-Alkoxyimino-2-pyrazolylakenylphenyl-acetamide derivs. of formula (I) are new: n = 0-4; m = 0-2; R<1> = NO2; CN; halo; 1-4C alkyl or alkoxy opt. substd. by halo; 1-4C alkylthio; phenyl or phenoxy opt. substd. by 1-5 halo and/or 1-3 NO2, CN, 1-4C alkyl or alkoxy (opt. substd. by halo) or 1-4C alkylthio; or 1,3-butadien-1,4-diyl bonded to 2 adjacent C atoms and opt. substd. by 1-4 halo and/or 1 or 2 NO2, CN, 1-4C alkyl or alkoxy (opt. substd. by halo) or 1-4C alkylthio; R<2> = H; opt. substd. alkyl, alkenyl or alkynyl; opt. substd. carbocyclic ring opt. contg. 1 or 2 double bonds and opt. 1-3 ), S and N atoms; or opt. substd. mono- or bicyclic aromatic ring opt. contg. 1-4 N atoms and 1 O or S atom or 1 O or S atom; R<3> = NO2; CN; halo; or 1-4C alkyl or alkoxy opt. substd. by halo; R<4> = H; CN; halo; or 1-4C alkyl opt. substd. by halo.
Patent NZ-302513-A (NZ)
Title: Chimeric receptors for redirecting cellular immunity
Inventor: SEED BRIAN
IPC: C12N5/07
Filed: 1996-01-25
Abstract: Disclosed is a method of directing a cellular response in a mammal by expressing in a cell of the mammal at least two chimeric receptors which trigger the specific recognition and destruction of an infective agent.  These are expressed in a cell infected with an infective agent, a tumour or cancerous cell, or an autoimmune generated cell.  One of the expressed chimeric receptors includes an extracellular portion that is capable of specifically recognising and binding the target cell or target infective agent and an intracellular or transmembrane portion.  The portion is capable of signaling the therapeutic cell to destroy a receptor-bound target cell or a receptor-bound target infective agent; and the second chimeric receptor includes an extracellular portion which is capable of specifically recognizing and binding the target cell or target infective agent and an intracellular portion which is derived from CD28. Also disclosed are pairs of useful chimeric receptors, cells that express the chimeric receptors, and DNA encoding the chimeric receptors.
Patent NZ-302611-A (NZ)
Title: Induction air handling unit has an induction chamber and a nozzle with a scalloped edge shape
Inventor: LUXTON RUSSELL ESTCOURT
IPC: F24F13/26
Filed: 1996-03-11
Abstract: PCT No. PCT/AU96/00129 Sec. 371 Date Sep. 10, 1997 Sec. 102(e) Date Sep. 10, 1997 PCT Filed Mar. 11, 1996 PCT Pub. No. WO96/28697 PCT Pub. Date Sep. 19, 1996This invention relates to an induction air handling unit of the type that uses a primary air flow to induce flow of secondary air through the air handling unit. It comprises an induction chamber (2) having an air flow entrance (22) and an air flow exit (23) and a nozzle (10) having an outlet (12) located within the induction chamber (20). The nozzle (10) is connected to a primary air flow that causes a secondary air flow to be induced through the induction chamber (20) via the entrance (22) and the exit (23). The nozzle (10) is characterized by the edge (12) forming an outlet that is of a scalloped shape. This has a dramatic effect on producing noise output from the nozzle (10).
Patent NZ-316551-A (NZ)
Title: Visual display means incorporating loudspeakers comprises transducers mounted wholly and exclusively on the housing
Inventor: AZIMA HENRY
IPC: H04N5/64
Filed: 1996-09-02
Abstract: The visual display unit (137) comprises a display screen (37) and a housing (101) in which the display screen is mounted. The housing carries a loudspeaker (81) comprising a distributed mode acoustic radiator (2) and a transducer (9) mounted wholly and exclusively on the radiator to vibrate the radiator to cause it to resonate. The radiator may be integral with the housing, e.g. an external wall of the housing. The radiator may comprise a stiff lightweight panel having a cellular core sandwiched by skin layers, one of which skin layers is integral with the housing. The skin layer may be thinner than the average wall thickness of the housing. The external wall of the housing may be formed with a groove which surrounds the radiator and which defines a resilient suspension coupling the loudspeaker to the housing.
Patent NZ-319877-A (NZ)
Title: Butyrate prodrugs of lactic acid
Inventor: TUNG ROGER D
IPC: C07C69/68
Filed: 1996-09-30
Abstract: This invention relates to butyrate prodrugs derived from lactic acid and pharmaceutical compositions and methods employing them, either alone or in combination with other agents, for increasing gamma globin and fetal hemoglobin in a patient. These compounds, compositions and methods are particularly effective in treating  beta -hemoglobinopathies, including sickle cell syndromes and  beta -thalassemia syndromes. In addition, this invention relates to the use of these prodrugs, alone or in combination with other agents, to stimulate cell differentiation which prevents proliferation of malignant cells. These methods are particularly useful in treating cancer, especially malignant hematological disorders.
Patent NZ-321366-A (NZ)
Title: Method of suspending inclusions
Inventor: SOKOLIK LINDA
IPC: A23L21/18
Filed: 1996-10-23
Abstract: A method for suspending inclusions in an acidic or alcoholic liquid composition is provided. The method includes the steps of preparing a pre-gel solution including gellan gum in water, providing a liquid composition having inclusions, incorporating the pre-gel solution into the liquid composition, and acidifying the liquid composition to produce a beverage and suspend the inclusions in the beverage. Alternatively, the liquid composition can be provided without inclusions and the inclusions may be added after the pre-gel solution is incorporated into the liquid composition to form a suspending solution or after the suspending solution is acidified to produce a beverage.
Patent NZ-323666-A (NZ)
Inventor: FAROOQ SALEEM
IPC: A01N37/38
Filed: 1996-11-25
Abstract: ompounds of formula (I) in which n, q, A, X, G, Y, Z, R, R2, R3, R4, R5, R7 and R9 are as defined in claim 1, and, where appropriate, E/Z isomers, E/Z isomer mixtures and/or tautomers thereof, in each case in the free form or in an agrochemically suitable salt form, can be used as agrochemical active compounds and can be prepared in a manner known per se.
Patent NZ-331011-A (NZ)
Title: Azolyl piperazinyl phenyl oxazolidinone antimicrobials
Inventor: GADWOOD ROBERT C
IPC: C07D263/26
Filed: 1997-02-18
Abstract: Compounds useful in the preparation of pharmaceutical preparations for the treatment of microbial infection including such pathogens such as gram-positive aerobic bacteria (multiply-resistant staphylococci, streptococci and enterococci), as well as anaerobic organisms such as Bacteroides spp., and acid-fast organisms such as Mycobacterium tuberculosis. Where such compounds are of structural formula (I) or pharmaceutically acceptable salts thereof. Wherein: R1 is -CHO, -COCH3, -COCHCl2, -COCHF2, -CO2CH3, -SO2CH3, or -COCH2OH; X1 and X2 are independently H, F, or Cl; and Q is a five-membered ring heterocycle (azolyl ring) of general form (a) wherein A, B, and C, are independently oxygen (O), nitrogen (N), sulfur (S) or carbon (C). In all cases, the piperazine nitrogen atom is attached at the carbon atom of the carbon-nitrogen double bond.
Patent NZ-333099-A (NZ)
Title: synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
IPC: A61P31/18
Filed: 1997-06-23
Abstract: The synergistic combination comprises: a) 3S-[3R*(1R*,2S*)-[3-[[(4-aminophenyl)sulphonyl]-(2-methylpropyl)-amino]-2-hydroxy-1-(phenylmethyl)-propyl]carbamic acid, tetrahydro-3-furanyl ester also known as 141W94; b) 3'-azido-3'-déoxythymidine also known as zidovudine and c) (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one also known as 3TC. The pharmaceutical compositions thereof are useful in the treatment of HIV infections including infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors.
Patent NZ-333283-A (NZ)
Title: Pesticidal compositions comprising a butanole-ethoxylate/propoxylate block copolymer
Inventor: VOGT MANFRED
IPC: A01N37/46
Filed: 1997-06-19
Abstract: A liquid pesticidal composition, substantially free of water, comprising a hydrophobic pesticide or mixture of pesticides dissolved in an organic solvent and comprising as surfactants (1) a butanole-ethoxylate/propoxylate-blockcopolymer having 12-30 mol ethoxylate and 16-48 mol propoxylate, in combination with (2) a branched C8-C18 alcohol ethoxylate having 5-10 mol ethoxylate, and/or (3) a tristyrenephenol-ethoxylate having 8-30 mol ethoxylate, or its phosphate or salt thereof. The compositions include also gels having a viscosity of 500 to 20'000 mPas and comprising additionally a gelling agent.
Patent NZ-501079-A (NZ)
Title: Free-piston engine with frequency control module, starting module and power transforming module interconnected by segmented rod and couplings
Inventor: BORISSENKO VLADIMIR IVANOVICH
IPC: F02B71/00
Filed: 1998-05-26
Abstract: Frequency control module 16, starting module 18 and power transforming module 19 (and optionally motion control module 17) are interconnected by couplings 11 to 15 to segmented rod 10.
Patent NZ-501360-A (NZ)
Title: Concentrated fibrin monomer solutions useful as fibrin sealants
Inventor: EDWARDSON PETER A D
IPC: A61K35/14
Filed: 1998-06-09
Abstract: A fibrin monomer composition comprising a solution of 10-30 mg/ml of fibrin monomer, 10-40 mg/ml of prothrombin, and 5-100 mg/ml of activatable Factor XIII.  The method of forming the fibrin monomer involves taking a blood sample from a patient, harvesting from the blood the fibrin, prothrombin, Factor XIII composition and polymerizing the solution to form the fibrin polymer.  The fibrin polymer is suitable for use on or in the same patient
Patent NZ-501919-A (NZ)
Title: Methods for analyzing nucleic acid molecules utilizing mass spectroscopy readable tags
Inventor: VAN NESS JEFFREY
IPC: G01N27/62
Filed: 1998-07-22
Abstract: A compound of the formula: Tms- L-X wherein; Tms is an organic group detectable by mass spectrometry, comprising carbon, at least one of hydrogen and fluoride, and optional atoms selected from oxygen, nitrogen, sulphur, phosphorus and iodine; L is an organic group which allows a unique Tms-containing moiety to be cleaved from the remainder of the compound, wherein the Tms-containing moiety comprises a functional group which supports a single ionized charge state when the compound is subjected to mass spectrometry and is tertiary amine, quaternary amine or organic acid; X is a functional group selected from phosphoramidite and H-phosphonate. A method is provided for determining the presence of nucleotide polymorphisms in a nucleic acid target comprising: a) amplifying a sequence of a nucleic acid target containing a single nucleotide polymorphism; b) generating a single strand form of the target; c) combining a tagged nucleic acid probe with the amplified target nucleic acid molecules under conditions and for a time sufficient to permit hybridization of the tagged nucleic acid probe to complementary amplified selected target nucleic acid molecules, wherein the tag has the structure:      T-L-X wherein, T is an organic group detectable by spectrometry or potentiometry and correlative with a particular single nucleotide polymorphism, L is an organic group which allows an T-containing moiety to be cleaved from the remainder of the tagged nucleic acid, and X is a nucleic acid probe; d) separating unhybridized tagged probe from hybridized tagged probe by a sizing methodology; e) cleaving the tag from the probe; and f) detecting the tag by spectrometry or potentiometry, and determining the presence of the single nucleotide polymorphism.